Examining productivity losses associated with health related quality of life using patient and general population data

The work described in this report was commissioned by the Department of Health to inform its work on Value-Based-Pricing (VBP), which is due to replace the current Pharmaceutical Pricing Regulation Scheme (PPS) in January 2014 for pricing medicines in the UK. VBP will include additional payments to interventions that are deemed to provide benefit that is of greater social value instead of the current narrow focus on outcomes relevant to the NHS and Personal Social Services (PSS). This requires taking into account wider societal benefits of medicines beyond the health of the patient including productivity. The objective of the analyses was to provide a model to predict productivity losses associated with paid work that were representative of all patients that are likely to be seen in the NHS.